Suubi4PrEP: Improving PrEP Access and Adherence for Young Women in Uganda

This study, called Suubi4PrEP, is looking for 600 young women in Uganda, aged 15-24, who are at high risk for HIV. The goal is to find better ways to help them start and continue using PrEP (pre-exposure prophylaxis), which is a medicine that can prevent HIV. The study will test a combination of approaches: HIV risk reduction sessions that include information about PrEP, support from peer mentors who are already taking PrEP, and a program that helps with saving money and learning about finances. Researchers will measure how many participants start using PrEP at the beginning of the study and then again at 12, 24, and 36 months. The current status of this study is unclear.

Study design
This interventional study plans to enroll 600 participants. It will test a combination of behavioral interventions.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for PrEP initiation at 12, 24, and 36 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07002866

Suubi4PrEP: Improving PrEP Access and Adherence Among Adolescent Girls and Young Women in Uganda

Recruiting
NAAges 15–24InterventionalPrevention
Washington University School of Medicine
~600 participants
Updated 2025-11-05 on ClinicalTrials.gov
What's tested:HIV Risk Reduction (HIVRR)PrEP Peer Supporters (PS)Matched Savings Accounts + Financial Literacy (FL)

At a glance

Recruiting sites
1 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
PrEP Initiation
Measured over Baseline, 12, 24 and 36 months
HIV Prevention
2 sites across 2 states
Missouri1
Uganda1

Opens a ready-to-send draft in your own email app — review before sending.

  • PrEP InitiationBaseline, 12, 24 and 36 months

    Proportion of eligible participants who initiate PrEP